Hispanica International Delights of America, Inc. announced the appointment of Bassam Damaj, PhD to its Board of Directors. Dr. Damaj brings with him the expertise of navigating the public markets. He currently serves as President & CEO of Innovus Pharma. Prior to joining Innovus, Dr. Damaj served as President & Chief Executive Officer of Apricus Biosciences, Inc., from December 2009 until November 2012. Before Apricus, Dr. Damaj was a co-founder of Bio-Quant, Inc. At Bio-Quant, he served as the Chief Executive Officer, Chief Scientific Officer and Director from its' inception in June 2000 until its acquisition by Apricus Biosciences in December 2009. In addition, Dr. Damaj was the founder, Chairman, President & Chief Executive Officer of R&D Healthcare, and the co-founder of Celltek Biotechnologies.